Home
About
Overview
Sharing Data
ORCID
Help
History (18)
The Pediatrician's Moral Obligation to Counsel Directively Against Youth Tackle Football.
Iliac arteriovenous fistulas after lumbar spinal surgery.
Aldrich Lifetime Achievement
Principal Investigator
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy. Aliment Pharmacol Ther. 2018 07; 48(1):65-77.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal
Crohn Disease
Female
Follow-Up Studies
Humans
Induction Chemotherapy
Maintenance Chemotherapy
Male
Middle Aged
Remission Induction
Time Factors
Treatment Outcome
Ustekinumab
authors with profiles
Stephen B. Hanauer